Choroidal Neovascularization - 25 Studies Found Withdrawn : Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID). : Choroidal Neovascularization in Angioid Streaks : 2015-10-07 : Drug: Aflibercept The patients are followed on a monthly basis until 52 weeks. Intravitreal injections o Completed : Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization. : Choroidal Neovascularization (CNV) : 2013-04-23 : Drug: Ranibizumab Ranibizumab Completed : Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization : Subfoveal Choroidal Neovascularization : 2006-12-01 : Drug: intravitreal injection of ranibizumab Completed : Efficacy and Safety of Ranibizumab 0.5 vs Veteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia : Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia : 2013-08-12 : Drug: Ranibizumab 0.5mg 0.5 mg Completed : Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration. : Choroidal Neovascularization : 2006-11-01 : Drug: ranibizumab 0.5mg intravitreal injection Completed : Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks : Angioid Streaks Choroidal Neovascularization : 2006-06-30 : Drug: Intravitreal Bevacizumab Completed : Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia : Choroidal Neovascularization Myopia, Degenerative : 2011-08-22 : Drug: Combretastatin A-4 Phosphate Combretastatin A-4 Phosphate is administered on Day 0 and Day 7 (+/- Recruiting : AVENUE: A Proof-of-Concept Study of RG7716 in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) : Macular Degeneration, Choroidal Neovascularization : 2015-06-12 : Drug: RG7716 Participants will Completed : Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization : Macular Degeneration Choroidal Neovascularization : 2007-02-16 : Drug: Verteporfin Photodynamic Therapy Completed : A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia. : Choroidal Neovascularization Secondary to Pathologic Myopia : 2014-01-09 : Drug: Ranibizumab All patients will receive a single initial intravitreal injection of ranibizumab 0.5 m <<< Previous | Next >>>